OSF: https://osf.io/sd5g4/
There’s evidence that fully or partially knocking out TMEM2 / hyaluronidase causes developmental problems, including in the heart. So you can’t just aggressively modify hyaluronan turnover during early development without consequences. I'm thinking - metabolism.
"A role for heavy chain-modification in protecting hyaluronan from free radical fragmentation during inflammation."
www.biorxiv.org/content/10.6...
"A role for heavy chain-modification in protecting hyaluronan from free radical fragmentation during inflammation."
www.biorxiv.org/content/10.6...
There’s evidence that fully or partially knocking out TMEM2 / hyaluronidase causes developmental problems, including in the heart. So you can’t just aggressively modify hyaluronan turnover during early development without consequences. I'm thinking - metabolism.
There’s evidence that fully or partially knocking out TMEM2 / hyaluronidase causes developmental problems, including in the heart. So you can’t just aggressively modify hyaluronan turnover during early development without consequences. I'm thinking - metabolism.
There’s evidence that fully or partially knocking out TMEM2 / hyaluronidase causes developmental problems, including in the heart. So you can’t just aggressively modify hyaluronan turnover during early development without consequences. I'm thinking - metabolism.
pubmed.ncbi.nlm.nih.gov/40661163/
pubmed.ncbi.nlm.nih.gov/40661163/
There’s evidence that fully or partially knocking out TMEM2 / hyaluronidase causes developmental problems, including in the heart. So you can’t just aggressively modify hyaluronan turnover during early development without consequences. I'm thinking - metabolism.
There’s evidence that fully or partially knocking out TMEM2 / hyaluronidase causes developmental problems, including in the heart. So you can’t just aggressively modify hyaluronan turnover during early development without consequences. I'm thinking - metabolism.
Prime tissue with HA precursors (UDP-sugars), then apply a brief HIF-2α–leaning pseudohypoxic pulse under low-ROS conditions without drifting into HIF-1α. Repeat.
Possible?
Prime tissue with HA precursors (UDP-sugars), then apply a brief HIF-2α–leaning pseudohypoxic pulse under low-ROS conditions without drifting into HIF-1α. Repeat.
Possible?
Seems Hyaluronan turnover would be required for plasticity
www.nature.com/articles/s41...
Seems Hyaluronan turnover would be required for plasticity
www.nature.com/articles/s41...
Sulforaphane helps protect CD44, reducing HA breakdown and receptor shedding + activates NRF2
Starch-heavy diets push glycolysis, supplying substrate to make long chains
I can imagine a previous human with rock hard skin, we would look like babies in comparison
Sulforaphane helps protect CD44, reducing HA breakdown and receptor shedding + activates NRF2
Starch-heavy diets push glycolysis, supplying substrate to make long chains
I can imagine a previous human with rock hard skin, we would look like babies in comparison
Aaron became a statistician, and I become a biologist.
We have now collaborated on an interesting exploration: doi.org/10.64898/202...
Aaron became a statistician, and I become a biologist.
We have now collaborated on an interesting exploration: doi.org/10.64898/202...
The cell surface hyaluronidase TMEM2 plays an essential role in mouse neural crest cell development and survival
www.biorxiv.org/content/10.1...
The cell surface hyaluronidase TMEM2 plays an essential role in mouse neural crest cell development and survival
www.biorxiv.org/content/10.1...
www.science.org/doi/10.1126/...
Embryo: HA turns over in hours
Fetus: slows to hours–days
Postnatal: slows further to days–weeks
Late teens/20's: peak
Aging: creation slows, degradation speeds up - body gradually “dries out”.
Slow it down just a little..
Embryo: HA turns over in hours
Fetus: slows to hours–days
Postnatal: slows further to days–weeks
Late teens/20's: peak
Aging: creation slows, degradation speeds up - body gradually “dries out”.
Slow it down just a little..
There’s scattered evidence that low-molecular-weight hyaluronan activates TLR2/4, and that TLR2/4 signalling shapes microglial activity.
Any experts?
There’s scattered evidence that low-molecular-weight hyaluronan activates TLR2/4, and that TLR2/4 signalling shapes microglial activity.
Any experts?
If glycolysis drives long HA and long HA stabilizes tissue, then paradoxically glycolysis + HA might be protective, not carcinogenic?
If glycolysis drives long HA and long HA stabilizes tissue, then paradoxically glycolysis + HA might be protective, not carcinogenic?
Many species that evolve to be more social or less aggressive also show neoteny — they keep youthful traits for longer.
Not just in appearance, but in the brain: plasticity, longer learning windows, emotional sensitivity.
Many species that evolve to be more social or less aggressive also show neoteny — they keep youthful traits for longer.
Not just in appearance, but in the brain: plasticity, longer learning windows, emotional sensitivity.